Updated July 2026 · 8 min read

Aneurysmal Subarachnoid Hemorrhage for ICU Nurses 2026 — Two Deadlines, Days Apart

Part of the ICU Emergencies Hub — browse every related guide in one place.

Aneurysmal subarachnoid hemorrhage is one of the few ICU diagnoses with two separate killing windows. The first is immediate: an unsecured aneurysm can rebleed within hours, often fatally. The second arrives a week later, when delayed vasospasm can starve the brain of blood in a patient who looked stable. The nurse who understands both timelines — and whose serial neuro exam catches the subtle drift — is the early-warning system for both.

The presentation and the grading

The classic story is a sudden, severe headache that peaks in seconds — the thunderclap, "the worst headache of my life" — sometimes with brief loss of consciousness, vomiting, neck stiffness, or a seizure. Severity is captured by grading scales (Hunt and Hess, WFNS clinically; modified Fisher on the CT for blood burden), and those grades predict both outcome and vasospasm risk. A higher Fisher grade — more subarachnoid blood — means a higher chance of vasospasm later, which tells you which patients to watch most closely in the danger window.

Phase one: stop the rebleed

Before the aneurysm is secured, the enemy is rebleeding, and rebleeding carries very high mortality. The priorities until the clip or coil is placed:

Phase two: delayed cerebral ischemia and vasospasm

Days after the bleed — typically starting around day 4 and peaking through the second week — the cerebral arteries can narrow (vasospasm), reducing blood flow and causing delayed cerebral ischemia. This is the phase that turns a stable patient into a stroke, and it is why SAH patients stay in the ICU for two weeks. Management centers on three ideas:

Nimodipine for everyone. Oral nimodipine, a calcium channel blocker, is given to essentially every aneurysmal SAH patient because it improves neurologic outcomes. It does not reliably open the spasming vessel on angiography — its benefit is neuroprotective — so you give it on schedule regardless. Watch for hypotension; if the pressure drops, protocols often split the dose to smaller, more frequent dosing rather than skipping it.

Keep them euvolemic. The old "triple-H" therapy (hypertension, hypervolemia, hemodilution) has narrowed to maintaining normal volume and avoiding dehydration. Aggressive fluid loading is out; euvolemia is the target.

Raise the pressure for symptomatic spasm. When vasospasm causes a new deficit, the mainstay is induced hypertension — pushing the blood pressure up to force perfusion through the narrowed vessel. Refractory cases go to angiography for intra-arterial vasodilators or balloon angioplasty.

Why the neuro exam is the monitor

Also watch the sodium. SAH patients are prone to hyponatremia from cerebral salt wasting or SIADH, and a falling sodium both clouds the exam and worsens cerebral edema — a moving target that interacts with everything else you are managing.

The nursing bottom line

Hold two clocks at once. Early on, protect the unsecured aneurysm: control pressure, minimize straining, and get it clipped or coiled. Then, through the second week, become the vasospasm detector: give nimodipine on schedule, keep the patient euvolemic, know that the pressure goal has flipped to up for symptomatic spasm, and treat every serial neuro exam as the real monitor. Catching the drift early is how a nurse keeps delayed ischemia from becoming a completed stroke.

Related: Nimodipine · Mannitol & hypertonic saline for ICP · ICP monitoring & EVD management · Cerebral salt wasting vs SIADH

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.